Cargando…

Chemotherapy of HER2- and MDM2-Enriched Breast Cancer Subtypes Induces Homologous Recombination DNA Repair and Chemoresistance

SIMPLE SUMMARY: MDM2 is a protein responsible for negative regulation of the p53 tumor suppressor. In addition, MDM2 exhibits chaperone-like properties similar to the HSP90 molecular chaperone. Multiple studies revealed that MDM2 is deeply involved in cancer development and progression. Some recentl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herok, Marcin, Wawrzynow, Bartosz, Maluszek, Marta J., Olszewski, Maciej B., Zylicz, Alicja, Zylicz, Maciej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471926/ https://www.ncbi.nlm.nih.gov/pubmed/34572735 http://dx.doi.org/10.3390/cancers13184501

Ejemplares similares

Molecular chaperones in the acquisition of cancer cell chemoresistance with mutated TP53 and MDM2 up-regulation
por: Tracz-Gaszewska, Zuzanna, et al.
Publicado: (2017)

Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2
por: Wiech, Milena, et al.
Publicado: (2012)

Correction: Molecular Mechanism of Mutant p53 Stabilization: The Role of HSP70 and MDM2
por: Wiech, Milena, et al.
Publicado: (2013)

Diverse and cancer type-specific roles of the p53 R248Q gain-of-function mutation in cancer migration and invasiveness
por: Olszewski, Maciej Boleslaw, et al.
Publicado: (2019)

Heat shock proteins create a signature to predict the clinical outcome in breast cancer
por: Klimczak, Marta, et al.
Publicado: (2019)

High Guanine and Cytosine Content Increases mRNA Levels in Mammalian Cells
por: Kudla, Grzegorz, et al.
Publicado: (2006)

Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages
por: Donzelli, Sara, et al.
Publicado: (2018)

ZNF830 mediates cancer chemoresistance through promoting homologous-recombination repair
por: Chen, Guo, et al.
Publicado: (2018)

Alu and LINE-1 Hypomethylation Is Associated with HER2 Enriched Subtype of Breast Cancer
por: Park, So Yeon, et al.
Publicado: (2014)

Randomized DNA libraries construction tool: a new 3-bp ‘frequent cutter’ TthHB27I/sinefungin endonuclease with chemically-induced specificity
por: Krefft, Daria, et al.
Publicado: (2018)

A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance
por: Wang, Wei, et al.
Publicado: (2019)

BRCA2 and homologous recombination
por: Orelli, Brian J, et al.
Publicado: (2001)

Less Well-Known Consequences of the Long-Term Use of Opioid Analgesics: A Comprehensive Literature Review
por: Kotlińska-Lemieszek, Aleksandra, et al.
Publicado: (2022)

RNA‐mediated heterochromatin formation at repetitive elements in mammals
por: Stamidis, Nikolaos, et al.
Publicado: (2023)

HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer
por: Bergamino, Milana A., et al.
Publicado: (2022)

No observed effect of homologous recombination on influenza C virus evolution
por: Han, Guan-Zhu, et al.
Publicado: (2010)

Anatomy of Mdm2 and Mdm4 in evolution
por: Tan, Ban Xiong, et al.
Publicado: (2017)

Wild-type p53 oligomerizes more efficiently than p53 hot-spot mutants and overcomes mutant p53 gain-of-function via a “dominant-positive” mechanism
por: Walerych, Dawid, et al.
Publicado: (2018)

Promising approaches for the assembly of the catalytically active, recombinant Desulfomicrobium baculatum hydrogenase with substitutions at the active site
por: Witkowska, Malgorzata, et al.
Publicado: (2023)

Meta-Analysis of HER2-Enriched Subtype Predicting the Pathological Complete Response Within HER2-Positive Breast Cancer in Patients Who Received Neoadjuvant Treatment
por: Shen, Guoshuang, et al.
Publicado: (2021)

Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
por: Huun, Johanna, et al.
Publicado: (2017)

Chromatin as a sensor of metabolic changes during early development
por: Pladevall-Morera, David, et al.
Publicado: (2022)

Therapy-Induced Senescent/Polyploid Cancer Cells Undergo Atypical Divisions Associated with Altered Expression of Meiosis, Spermatogenesis and EMT Genes
por: Czarnecka-Herok, Joanna, et al.
Publicado: (2022)

Guidelines for Identifying Homologous Recombination Events in Influenza A Virus
por: Boni, Maciej F., et al.
Publicado: (2010)

A new genomic tool, ultra-frequently cleaving TaqII/sinefungin endonuclease with a combined 2.9-bp recognition site, applied to the construction of horse DNA libraries
por: Zylicz-Stachula, Agnieszka, et al.
Publicado: (2013)

Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype
por: van Wilpe, Sandra, et al.
Publicado: (2022)

A method for the transient inhibition of toxicity of secretory recombinant proteins, exemplified by bacterial alkaline phosphatase. Novel protocol for problematic DNA termini dephosphorylation
por: Krawczun, Natalia, et al.
Publicado: (2021)

The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells
por: Huun, Johanna, et al.
Publicado: (2017)

Decay energies of far unstable nuclei
por: Westgaard, L, et al.
Publicado: (1972)

New Insights into X-Chromosome Reactivation during Reprogramming to Pluripotency
por: Panda, Amitesh, et al.
Publicado: (2020)

Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways
por: Su, Wen-Pin, et al.
Publicado: (2017)

PAK6 promotes homologous-recombination to enhance chemoresistance to oxaliplatin through ATR/CHK1 signaling in gastric cancer
por: Huang, Weicai, et al.
Publicado: (2022)

HSPA2 Chaperone Contributes to the Maintenance of Epithelial Phenotype of Human Bronchial Epithelial Cells but Has Non-Essential Role in Supporting Malignant Features of Non-Small Cell Lung Carcinoma, MCF7, and HeLa Cancer Cells
por: Sojka, Damian Robert, et al.
Publicado: (2020)

Expression profile analysis of long noncoding RNA in HER-2-enriched subtype breast cancer by next-generation sequencing and bioinformatics
por: Yang, Fan, et al.
Publicado: (2016)

HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors
por: Daemen, Anneleen, et al.
Publicado: (2018)

A novel link between the HER2-Akt and MDM2-p53 pathways via CSN6
por: Iyer, Swathi V., et al.
Publicado: (2012)

Mouse models of Mdm2 and Mdm4 and their clinical implications
por: Xiong, Shunbin
Publicado: (2013)

Resveratrol chemosensitizes HER-2-overexpressing breast cancer cells to docetaxel chemoresistance by inhibiting docetaxel-mediated activation of HER-2–Akt axis
por: Vinod, B S, et al.
Publicado: (2015)

Validation of HER2 Status in Whole Genome Sequencing Data of Breast Cancers with the Ploidy-Corrected Copy Number Approach
por: Wojtaszewska, Marzena, et al.
Publicado: (2021)

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer
por: Lipton, Allan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1cd5186umksh7rq9foeiflvgq0